INSIGHTS ON DRUG DEVELOPMENT
-
![ai-data-analytics-GettyImages-2262212786]( "How To Benchmark Your Digital Transformation Performance And AI-Readiness")
How To Benchmark Your Digital Transformation Performance And AI-ReadinessAI investment is rising across life sciences, but data challenges stall real-world adoption. Discover what is holding teams back and how to turn AI potential into practical scientific impact.
-
![GettyImages-2029622961 lab]( "Best-In-Class Nanodevelopment Capabilities")
Best-In-Class Nanodevelopment CapabilitiesA highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.
-
![GettyImages-1309471798 respiratory]( "Outlining The Trends And Challenges In The Inhaled Drug Delivery Market")
Outlining The Trends And Challenges In The Inhaled Drug Delivery MarketExplore the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.
-
![Discovery Core Rheometer: Easy To Use. Hard To Beat.]( "Discovery Core Rheometer: Easy To Use. Hard To Beat.")
Discovery Core Rheometer: Easy To Use. Hard To Beat.Explore how advanced rheological testing delivers deeper insight into material behavior, from flow and yield stress to quality control decisions, using guided workflows that simplify setup.
-
Comprehensive And Streamlined Genomic Signature Assessment6/9/2026
Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.
-
Advancing Multiomics Through Intelligent Automation10/27/2025
Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.
-
Strategies For The Development Of Safe And Effective Pediatric Formulations5/12/2025
Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.
-
A Timeline Of U.S. Actions To Reduce Animal Models In Research6/25/2026
Policy and scientific validation have aligned to shift drug development beyond animal models. New regulations and technologies are making human‑relevant methods the standard for preclinical research.
-
Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives3/11/2026
By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-2193981513-3d-molecular-structure]( "Patient-Derived Assay-Ready Organoids")
Gain human-relevant insights with patient-derived assay-ready organoids.
-
![Pharma Services Support From The Idea To Production]( "Pharma Services: Support From The Idea To Production")
Connect pharmaceutical development, analytical testing and process engineering to reduce technical risk. Explore capabilities spanning formulation, characterization, dosing trials, and more.
-
Decades of experience in production technologies, quality control and knowledge of the regulatory environment result in high-quality drug delivery devices that are fully optimized to perform as a system.
-
![GettyImages-2067042854-DNA-strand-building-3d]( "Gain Human-Relevant Insights With Patient-Derived Assay-Ready Organoids")
3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
-
![iStock-1296470938-OSD-solid dose-capsule-softgel]( "Proprietary Patient-Centric Soft Lozenge Technology")
This patient-centric solution offers superior mouth comfort, customizable dissolution profiles, and robust taste-masking to accommodate diverse patient populations, including children and seniors.
